Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtre
1.
Experimental & Molecular Medicine ; : 538-538, 2011.
Article Dans Anglais | WPRIM | ID: wpr-7974

Résumé

No abstract available.

2.
Infection and Chemotherapy ; : 23-29, 2010.
Article Dans Coréen | WPRIM | ID: wpr-225194

Résumé

BACKGROUND: Legionella pneumophila is the causative agent of Legionnaires' disease, a severe form of pneumonia. After L. pneumophila is inhaled through contaminated aerosols, it is phagocytized by alveolar macrophages, multiplies in a specialized phagosome approximately 10 h postinfection, and eventually leads to the death of host cells. Currently available diagnostic tests for Legionella pneumonia have some limitations. This study was conducted to find diagnostic biomarkers for Legionella pneumonia using virulence gene expression profiling in a murine experimental model. MATERIALS AND METHODS: A/J mice were intranasally inoculated with L. pneumophila serogroup 1, and lungs were harvested 4, 8, 24, and 48 h postinfection. The strain grown in buffered yeast extract broth was used as reference samples. Cy-dye labeled cDNA samples were prepared with total RNA from lungs or broth culture, and hybridized on the oligo-microarray slide containing 2,895 genes of L. pneumophila serogroup 1. Virulence gene expression patterns were analyzed using a MIDAS software from TIGR (www.tigr.org). RESULTS: Among a total of 332 virulence genes examined, 17 genes including sidA, lepB, the genes related to flagella assembly (fliR and fliP), LPS lipid A biosynthesis, and the enhanced entry protein EnhA were up-regulated at all four time points. We further confirmed by quantitative real-time reverse transcription PCR that the expression of fliP gene was highly expressed in lung tissue as well as in bronchoalveolar lavage fluids from the mouse infected with L. pneumophila serogroup 1. CONCLUSIONS: Through gene expression analysis of L. pneumophila in a mouse model, several candidate biomarkers for diagnosing Legionnaires' disease could be identified.


Sujets)
Animaux , Souris , Aérosols , Marqueurs biologiques , Liquide de lavage bronchoalvéolaire , Chimère , Tests diagnostiques courants , ADN complémentaire , Flagelles , Expression des gènes , Analyse de profil d'expression de gènes , Legionella , Legionella pneumophila , Maladie des légionnaires , Lipide A , Poumon , Macrophages alvéolaires , Séquençage par oligonucléotides en batterie , Phagosomes , Pneumopathie infectieuse , Réaction de polymérisation en chaîne , Transcription inverse , ARN , Entorses et foulures , Levures
3.
Korean Journal of Clinical Microbiology ; : 7-13, 2010.
Article Dans Coréen | WPRIM | ID: wpr-87118

Résumé

BACKGROUND: Recently hepatitis A virus (HAV) infection has propagated among adults in Korea due to the epidemiologic shift in the age-specific HAV seroprevalence. There are apparently increase in symptomatic patients with severe diseases. This study aimed to investigate clinical and molecular characteristics related to acute kidney injury (AKI) occurrence in HAV infection. METHODS: A case-control study was conducted in a university hospital between February 2009 and July 2009. Clinical findings of non-fulminant HAV infection complicated with AKI (N=5) were compared to those without AKI (N=60). The complete sequence of the VP1 region (900 bp) was amplified from stool specimens by the RT-PCR to determine HAV genotypes and genetic variations between the two groups. RESULTS: Among 65 patients with non-fulminant HAV infections, 5 patients (7.7%) developed AKI. In multivariate analyses, higher level of C-reactive protein was independently associated with AKI occurrence in non-fulminant HAV infections [odds ratios=1.094, 95% confidence interval=1.011-1.183]. HAV RNA was detected in 57 (86.4%) patients: 53 strains (93.0%) showed genotype IIIA and 4 strains presented genotype IA. All HAV isolates from the AKI patients belonged to the genotype IIIA and shared the identical sequences with those from the non-AKI patients. CONCLUSION: This study indicates that higher level of C-reactive protein is associated with AKI occurrence in non-fulminant HAV infections. There were no specific nucleotide or amino acid substitutions in the VP1 region associated with AKI occurrence.


Sujets)
Adulte , Humains , Atteinte rénale aigüe , Substitution d'acide aminé , Protéine C-réactive , Études cas-témoins , Variation génétique , Génotype , Hépatite , Hépatite A , Virus de l'hépatite A , Corée , Analyse multifactorielle , ARN , Analyse de séquence , Études séroépidémiologiques
4.
Yonsei Medical Journal ; : 637-643, 2009.
Article Dans Anglais | WPRIM | ID: wpr-30697

Résumé

PURPOSE: This study was aimed to describe a vancomycin-resistant enterococci (VRE) outbreak across three intensive care units (ICUs) of a Korean hospital from September 2006 to January 2007 and the subsequent control strategies. MATERIALS AND METHODS: We simultaneously implemented multifaceted interventions to control the outbreak, including establishing a VRE cohort ward, active rectal surveillance cultures, daily extensive cleaning of environmental surfaces and environmental cultures, antibiotic restriction, and education of hospital staff. We measured weekly VRE prevalence and rectal acquisition rates and characterized the VRE isolates by polymerase chain reaction (PCR) of the vanA gene and Sma1-pulsed-field gel electrophoresis (PFGE). RESULTS: During the outbreak, a total of 50 patients infected with VRE were identified by clinical and surveillance cultures, and 46 had vancomycin-resistant Enterococcus faecium (VREF). PFGE analysis of VREF isolates from initial two months disclosed 6 types and clusters of two major types. The outbreak was terminated 5 months after implementation of the interventions: The weekly prevalence rate decreased from 9.1/100 patients-day in September 2006 to 0.6/100 by the end of January 2007, and the rectal acquisition rates also dropped from 6.9/100 to 0/100 patients-day. CONCLUSION: Our study suggests that an aggressive multifaceted control strategy is a rapid, effective approach for controlling a VRE outbreak.


Sujets)
Humains , Décontamination , Épidémies de maladies/prévention et contrôle , Enterococcus faecium/effets des médicaments et des substances chimiques , Infections bactériennes à Gram positif/traitement médicamenteux , Unités de soins intensifs , Isolement du patient , Prévalence , Résistance à la vancomycine
5.
Experimental & Molecular Medicine ; : 687-694, 2009.
Article Dans Anglais | WPRIM | ID: wpr-71514

Résumé

Legionella bacterium, an intracellular pathogen of mononuclear phagocytes, causes acute fatal pneumonia, especially in patients with impaired cellular immune responses. Until recently, however, the toll-like receptor (TLR) engagement of bacterial proteins derived from Legionella is uncertain. We previously showed that a 19-kDa highly conserved peptidoglycan-associated lipoprotein (PAL) of Legionella pneumophila induced the PAL-specific B cell and T cell responses in mice. In this study, we observed that the rPAL antigen of L. pneumophila, as an effector molecule, activated murine macrophages via TLR2 and produced proinflammatory cytokines such as IL-6 and TNF-alpha. In both BALB/c and TLR4-deficient C3H/HeJ mice, pretreatment of macrophages with anti-TLR2 mAb showed severely impaired cytokine production in response to the rPAL. In addition, in vitro the rPAL treatment increased the cell surface expression of CD40, CD80, CD86 and MHC I/II molecules. We further showed that the synthetic CpG-oligodeoxynucleotides (CpG ODN) coadministered with the rPAL enhanced IL-12 and IL-6 production and expression of CD40, CD80 and MHC II compared to the rPAL treatment alone. In conclusions, these results indicate that Legionella PAL might activate macrophages via a TLR2-dependent mechanism which thus induce cytokine production and expression of costimulatory and MHC molecules.


Sujets)
Animaux , Femelle , Souris , Antigènes CD/immunologie , Protéines de la membrane externe bactérienne/pharmacologie , Cellules cultivées , Antigènes d'histocompatibilité de classe II/immunologie , Interactions hôte-pathogène , Interleukine-12/biosynthèse , Interleukine-6/biosynthèse , Legionella pneumophila/immunologie , Maladie des légionnaires/immunologie , Lipoprotéines/pharmacologie , Activation des macrophages/effets des médicaments et des substances chimiques , Macrophages péritonéaux/effets des médicaments et des substances chimiques , Souris de lignée BALB C , Souris de lignée C3H , Souris de lignée C57BL , Récepteur de type Toll-2/métabolisme , Facteur de nécrose tumorale alpha/biosynthèse
6.
Journal of Korean Medical Science ; : 762-766, 2008.
Article Dans Anglais | WPRIM | ID: wpr-37046

Résumé

The origin of methicillin-resistant Staphylococcus aureus (MRSA) strains from otolaryngology outpatients has not been evaluated yet in Korea. We analyzed epidemiologic and genetic characteristics of MRSA isolates from the ear discharge of 64 outpatients with chronic otitis media in a Korean University Hospital during 2004. MRSA strains were grouped as either from the initial visit (n=33) or the follow-up visit (n=31) based on the timing of isolation. Healthcare-associated risk factors were frequently present among patients of the initial visit group, especially prior visit to primary clinic (79%) and antibiotic use (73%). SCCmec typing and multilocus sequence typing results showed that two genotypes, ST5-MRSA-II and ST239-MRSAIII, were prevalent in both the initial visit (73% vs. 24%) and the follow-up visit (55% vs. 42%). Pulsed-field gel electrophoresis identified eight types, including two major types shared by both groups. We conclude that majority of MRSA strains from ear discharge of chronic otitis media belonged to nosocomial clones that might be circulating in the community. This is the first report of the genetic analysis of MRSA strains from otolaryngology practices in Korea.


Sujets)
Adolescent , Adulte , Sujet âgé , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Adulte d'âge moyen , Techniques de typage bactérien , Maladie chronique , Génotype , Staphylococcus aureus résistant à la méticilline/génétique , Otite moyenne suppurée/complications , Polymorphisme de restriction , Facteurs de risque , Infections à staphylocoques/complications
7.
Journal of Korean Medical Science ; : 602-607, 2006.
Article Dans Anglais | WPRIM | ID: wpr-191674

Résumé

Local epidemiologic data on the etiologies of patients hospitalized with community-acquired pneumonia (CAP) is needed to develop guidelines for clinical practice. This study was conducted prospectively to determine the proportion of atypical bacterial pathogens in adults patients hospitalized with CAP in Korea between October 2001 and December 2002. Microbiological diagnosis was determined by serology for antibodies to Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneu-mophila. Nucleic acid of M. pneumoniae and C. pneumoniae in respiratory samples and Legionella antigen in urine samples were detected. The study population consisted of 126 patients (71 males, 55 females), averaging 54.6 yr (SD+/-17.8), whose paired sera were available. An etiologic diagnosis for atypical pathogens was made in 18 patients (14.3%): C. pneumoniae 9 (7.1%), M. pneumoniae 8 (6.3%), and L. pneumophila 3 patients (2.4%). Streptococcus preumoniae and other typical pathogens were isolated from 36 patients (28.6%). Of 126 patients, 16 (12.7%) were admitted to intensive care unit and atypical pathogens were identified in 5 patients (31.3%). Initial clinical features of patients with pneumonia due to atypical, typical or undetermined pathogens were indistinguishable. We conclude that atypical pathogens should be seriously considered in hospitalized patients with CAP, when initiating empiric treatment in Korea.


Sujets)
Adulte d'âge moyen , Mâle , Humains , Femelle , Sujet âgé , Adulte , ARN ribosomique 16S/génétique , Études prospectives , Réaction de polymérisation en chaîne , Pneumopathie bactérienne/sang , Mycoplasma pneumoniae/génétique , Legionella pneumophila/génétique , Corée , Hospitalisation/statistiques et données numériques , Infections communautaires/microbiologie , Chlamydophila pneumoniae/génétique , Antigènes bactériens/urine , Anticorps antibactériens/sang
SÉLECTION CITATIONS
Détails de la recherche